In the latest quarter, 7 analysts provided ratings for Madrigal Pharmaceuticals (NASDAQ: MDGL), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...

Madrigal Pharmaceuticals (NASDAQ:MDGL) has received conditional marketing approval from the European Commission for Rezdiffra (resmetirom) for non-cirrhotic metabolic dysfunction-associated ...

Salt-N-Pepa say UMG is blocking access to their master recordings and pulling their music from streaming ahead of their Rock & Roll Hall of Fame induction. Salt-N-Pepa are accusing UMG of deliberately ...

Salt-N-Pepa filed a lawsuit against Universal Music Group in May. The women behind Salt-N-Pepa, the history-making female hip-hop group, claim that Universal Music Group has removed some of their ...

Salt-N-Pepa are speaking out about their legal battle with Universal Music Group. In a new interview with Good Morning America, the rap duo — Cheryl “Salt” James and Sandra “Pepa” Denton — explained ...

When Salt-N-Pepa entered the music industry 40 years ago, they paved a way for women in the industry. Now the members of the first female rap group to go platinum hope to inspire more artists to fight ...

Two years had passed since Malachi Henry competed in a triathlon, and for him, it was a long two years. Aftter turning pro, Henry underwent one surgery on the labrum in his left hip and three ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra showed strong Q1 2025 sales of $137.3M that highlight robust U.S. demand and early commercial momentum in non-cirrhotic NASH patients. Key catalysts include ...

July 30 (Reuters) - U.S. drugmaker Madrigal Pharmaceuticals (MDGL.O), opens new tab has struck a licensing deal with CSPC Pharmaceutical Group (1093.HK), opens new tab that could be worth more than $2 ...

PHOENIX (AZFamily) — A Valley favorite has reopened at a new location after a fire destroyed its original restaurant last year. The fire devastated Cocina Madrigal in March 2024. Investigators say it ...

In trading on Wednesday, shares of Madrigal Pharmaceuticals Inc (Symbol: MDGL) crossed above their 200 day moving average of $294.07, changing hands as high as $300.94 per share. Madrigal ...